Release Date: 17/08/21 17:44 Summary: Second Quarter Results Presentation Price Sensitive: No Download Document 1.74MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%